Male Contraception – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Male Contraception – Drugs In Development, 2024 report and make more profitable business decisions.
Male contraception is a reduction of the number of fertile sperm ejaculated into the vagina to levels that reliably prevent fertilization. Conception can be prevented by diverting or suppressing sperm output or by inhibiting sperm fertilizing capacity. So far, all male methods depend on mechanical means to reduce female exposure to sperm using either traditional drug and device-free methods (abstinence, withdrawal, or non-vaginal intercourse) or contemporary male methods comprising condoms and vasectomy.
The Male Contraception drugs in development market research report provide comprehensive information on the therapeutics under development for Male Contraception, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Male Contraception and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Male Contraception | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 11 molecules, with 8 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Male Contraception therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Male Contraception pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Male Contraception treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Beijing FuKangren Bio-pharm Tech Co LtdDare Bioscience Inc
Eppin Pharma Inc
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Lyndra Therapeutics Inc.
Orphagen Pharmaceuticals Inc
Spermatech AS
The Population Council Inc
Vibliome Therapeutics Inc
YourChoice Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Male Contraception reports